- ... 557.337.539.250 Leukemia, Myelogenous, Chronic, BCR-ABL Positive C04.557.337.539.250.100 Blast ... 337.539.300 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Nega tive C04.557.337.539.520 Leukemia, ...
- ... Mast-Cell Leukemia, Myeloid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Blast Crisis Leukemia, Myeloid, Accelerated Phase Leukemia, ... Leukemia, Promyelocytic, Acute Leukemia, Myeloid, Chronic, Atypical, ... Acute Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, ...
- ... 557.337.539.250...........................................Leukemia, Myelogenous, Chronic, BCR-ABL Positive C04.557.337.539.250.100...........................................Blast ...
- ... ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of ... inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID ...
- ... hemagglutinin and neuraminidase activity) ONCOGENE PROTEINS, FUSION BCR-ABL FUSION PROTEINS (translation product of fusion mRNAs) GAG- ... WILMS' TUMOR (PROTO-ONCOGENES) [notnew for 1991] GENES, ABL GENES, FMS GENES, MOS GENES, MIC GENES, SRC ...
5 results